USPTO serial 86104231
BIOLUTE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ORTIGA PALMER, RAMONA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOLUTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
8180 Bülach, CH
8180 Bülach, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Fraser
JENNIFER FRASER Dykema Gossett PLLC1301 K Street N.W.Suite 1100 WestWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical coatings used in the manufacture of medical stents; Chemical and biochemical preparations for industrial and scientific purposes, namely, polylactide, polymers and silicone | ACTIVE | — |
| 005 | Chemical or pharmaceutical preparations for medical purposes, namely, polymerdrug preparations, namely, polymer-drug preparation, namely, polylactide-limus preparations, namely, drug preparations in the nature of drug delivery agents in the form of a coating that facilitate the delivery of pharmaceutical preparations; chemical or pharmaceutical preparations, namely, delivery agents in the form of a coating for medical stents that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, a drug delivery system comprising polymer-based coatings for the release of a wide variety of therapeutic agents; chemical pharmaceutical preparations for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; drugs, namely, paclitaxel, and limus drug family, in particular sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for medical purposes for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; surgical implants comprising living tissues ; medicines for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation for human purposes | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants and apparatus in the nature of stents; coatings for medical devices or chemical or pharmaceutical preparations used for stents, namely, coatings sold as an integral component of medical stents; surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; Catheters and parts therefor, catheters for percutaneous coronary intervention (PCI), catheters for percutaneous transluminal coronary angioplasty (PTCA catheters), and catheters for percutaneous transluminal angioplasty (PTA catheters), in particular catheters for balloon dilatation; medical guidewires; medical apparatus and instruments, namely, balloons and stents and parts therefor, balloon expandable stents, self expandable stents, drug eluting stents, absorbable stents, and absorbable implantable scaffolds comprising artificial materials, coronary and peripheral balloon catheters, drug eluting balloons, drug releasing balloons, drug coated balloons | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOTRONIK AG
- Other trademarks owned by BIOTRONIK AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BIOLUTE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 2, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 29, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 28, 2017 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 27, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 21, 2017 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 21, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 8, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 5, 2017 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 5, 2017 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 5, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 15, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 12, 2016 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 19, 2016 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 19, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 28, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 26, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 24, 2016 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 22, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 21, 2016 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 21, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 21, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 13, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 13, 2015 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 13, 2015 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 13, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 2, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 26, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 31, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 24, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 21, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 19, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 19, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 19, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 26, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2013 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 2, 2013 | ALIE | ASSIGNED TO LIE | — |
| Nov 20, 2013 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 5, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 1, 2013 | NWAP | NEW APPLICATION ENTERED | — |